Faruqi & Faruqi, LLP Investigates Claims on Behalf of – FINAL DEADLINE NOTICE
Investors who suffered losses exceeding $50,000 in Metagenomi between February 9, 2024, and September 26, 2024, now have a reminder from Faruqi & Faruqi, LLP about their opportunity to discuss their options. If this applies to you, don’t hesitate to reach out to Securities Litigation Partner James (Josh) Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Faruqi & Faruqi, LLP, a respected national securities law firm, is currently investigating potential claims against Metagenomi, Inc. (“Metagenomi” or the “Company”) (NASDAQ: MGX). The firm wants to make sure investors are aware of the upcoming deadline on November 25, 2024, to seek the role of lead plaintiff in a federal securities class action against the Company.
The complaint alleges that the Company and its executives may have violated federal securities laws by not being truthful about their collaboration agreement with Moderna. Metagenomi initially presented itself to investors during its initial public offering as a “genetic medicines company” with a significant partnership with Moderna, a prominent Covid-19 vaccine company. However, just a few months after its IPO, on May 1, 2024, Metagenomi shared that it had decided to end its collaboration with Moderna. This unexpected news caused Metagenomi’s stock price to drop from $7.04 per share to $6.17 per share the next day.
As the investigation unfolds, Faruqi & Faruqi, LLP, is ready to assist anyone with information regarding Metagenomi’s conduct, including whistleblowers, former employees, shareholders, and more. To stay updated on the Metagenomi class action and learn how to potentially participate, visit www.faruqilaw.com/MGX or contact Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
It’s essential to remember that the court-appointed lead plaintiff plays a crucial role in the class action, directing and overseeing the litigation on behalf of the class. Anyone interested in this opportunity can take action by reaching out to Faruqi & Faruqi, LLP. Your ability to recover losses is not affected by whether you choose to serve as a lead plaintiff or remain an absent class member.
For additional updates and information, you can follow Faruqi & Faruqi, LLP on LinkedIn, X, or Facebook. Remember, prior results do not guarantee a similar outcome in the future, but the team at Faruqi & Faruqi, LLP is ready to discuss your specific case in a confidential manner. If you have any questions or want to learn more, don’t hesitate to contact Faruqi & Faruqi at the provided phone numbers.
